Locations:

Tag: faricimab

February 23, 2024/Ophthalmology/Eye Care & Treatment

Faricimab Improves Results for Most Patients on Prior Therapy for nAMD

Switching medications may decrease treatment burden and macular fluid

21-EYE- 2468445- CQD – Faricimab in Neovascular

November 18, 2021/Ophthalmology/Ophthalmology Research

Effect of New Therapy Lasts Longer for Patients with Neovascular Age-Related Macular Degeneration

Faricimab every 16 weeks offers similar benefits as aflibercept every eight weeks

BackPage 1 of 1Next

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy